EZZ Life Science Holdings (ASX: EZZ) has entered into a major sales agreement with Hong Kong-based Pinehills for the supply of EZZ-branded products.
The five-year agreement with Pinehills has commenced and involves the purchase of EZZ-branded products with a total value of at least $15 million in the first 12-month period with a growth escalator applied in each subsequent year as outlined in the summary terms below.
The agreement with Pinehills provides EZZ with expanded distribution channels into the key markets of China and Vietnam as well as other markets within South East Asia.
"We are delighted to announce this significant sales agreement with Pinehills. Pinehills has established a strong distribution platform into key markets where we see growing demand for EZZ’s expanding range of products,” Glenn Cross, chairman of EZZ Life Science, said.
“This agreement is a testament to our commitment to growth and innovation, and we are confident that it will enhance our market reach and customer base as we collaborate further with Pinehills over coming years.”
Established in 2022 and headquartered in the Hong Kong, Pinehills Limited specialises in the distribution of maternal and infant health, skincare and cosmetics products. Pinehills’ management has extensive cross-border international trade experience and a comprehensive sales distribution network across China and a number of markets within South East Asia.
